Share on LinkedInShare on LinkedIn

ARTICLE · 21 AUGUST 2012

New Chapter In Dutch Cross-Border Practice

Yesterday the Dutch preliminary relief judge has ordered a Dutch defendant to stop the promotion and/or facilitation of patent infringement in Portugal.

NetherlandsIntellectual Property

Yesterday (August 16, 2012) the Dutch preliminary relief judge has ordered a Dutch defendant to stop the promotion and/or facilitation of patent infringement in Portugal.

Background

The plaintiff, Boehringer Ingelheim, is the holder of a Portuguese national patent for a process for the manufacturing of (inter alia) the compound nevirapine and also holds a corresponding SPC. The defendants, several entities of the Teva group, are based in the Netherlands and one of them is the holder of an EU marketing authorisation (MA) for a generic nevirapine product.

Teva introduced its generic nevirapine product on the market in Portugal - through their Portuguese daughter company - before expiry of the patent. Therefore, Boehringer Ingelheim initiated proceedings in Portugal to stop the infringement of its patent rights by Teva.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from